BioCentury
ARTICLE | Company News

Eisai sets Belviq price

February 26, 2013 1:32 AM UTC

Arena Pharmaceuticals Inc. (NASDAQ:ARNA) disclosed in an SEC filing that partner Eisai Co. Ltd. (Tokyo:4523; Osaka:4523) set a wholesale acquisition cost (WAC) of $199.50 for a one-month supply of twi...